Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Nevro Corp
NYSE:NVRO

Watchlist Manager
Nevro Corp Logo
Nevro Corp
NYSE:NVRO
Watchlist
Price: 5.84 USD Market Closed
Market Cap: $221.2m
Write Note Create Alert Ask AI

Nevro Corp
Investor Relations

Nevro Corp. engages in the provision of medical devices. The company is headquartered in Redwood City, California and currently employs 945 full-time employees. The company went IPO on 2014-11-06. The firm has developed and commercialized the Senza spinal cord stimulation (SCS) system. SCS is a neuromodulation platform for the treatment of chronic pain, with the Senza Omnia platform, which is in addition to the Senza family of products. The Company’s solution for chronic pain includes 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain based on what it believes to be the best clinical evidence available. The advantages of its 10 kHz Therapy over traditional SCS include demonstrated superior efficacy data for both leg and back pain, paresthesia free pain relief for patients, anatomical lead placement for physicians, and ability to treat a broader group of chronic pain patients.

Show more
Loading
NVRO
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2024
Call Date
Nov 11, 2024
Q3 2024 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Earnings Call Recording
Open Transcript
Other Earnings Calls

Management

Mr. Kevin R. Thornal
President, CEO & Director
No Bio Available
Mr. Roderick H. MacLeod
Senior VP & CFO
No Bio Available
Mr. Kashif Rashid J.D.
Senior VP of Corporate Development & Chief Legal Officer
No Bio Available
Mr. Greg Siller
Senior VP & Chief Commercial Officer
No Bio Available
Mr. Christofer Christoforou
Senior VP & COO
No Bio Available
Ms. Angeline C. McCabe
Vice President of Investor Relations & Corporate Communications
No Bio Available
Ms. Shana D. Ross M.B.A.
Senior VP & Chief Human Resources Officer
No Bio Available
Dr. David Caraway M.D., Ph.D.
Senior VP & Chief Medical Officer
No Bio Available
Mr. Peter A. Socarras
VP, General Counsel & Corporate Secretary
No Bio Available

Contacts

Address
CALIFORNIA
Redwood City
1800 Bridge Pkwy
Contacts
+16502510005.0
www.nevro.com
sparklesyt

See Also

Summary
NVRO intrinsic value, competitors valuation, and company profile.
DCF Valuation
NVRO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NVRO stock valuation using valuation multiples.
Wall Street Estimates
NVRO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NVRO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.